Alpha Tau Medical (DRTS) Income Statement: Revenue & Earnings

Alpha Tau Medical Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Alpha Tau Medical Ltd. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	1.10	0.00	0.00	0.00	0.00
Gross Profit	-1.10	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	27.02	26.42	20.89	11.45	7.54
Selling, General & Administrative	7.92	9.26	11.25	2.34	1.70
Operating Expenses	34.94	35.68	32.14	13.79	9.24
Operating Income	-36.04	-35.68	-32.14	-13.79	-9.24
Other Income/Expense
Interest Income	4.28	4.83	1.79	0.21	0.61
Interest Expense	0.34	-0.08	0.00	0.00	0.00
Other Income/Expense	4.30	1.82	-3.38	-13.67	-0.19
Income
Income Before Tax	-31.74	-42.22	-33.74	-27.26	-8.72
Income Tax Expense	0.01	-0.02	0.02	0.01	0.16
Net Income	-31.75	-42.20	-33.76	-27.27	-8.88
Net Income - Continuous Operations	-31.75	-29.16	-33.76	-27.27	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-30.30	-41.15	-32.76	-26.49	-9.16
EBIT	-31.74	-42.22	-33.74	-27.26	-9.24
Depreciation & Amortization	1.10	1.07	0.98	0.78	0.09
Earnings Per Share
Basic EPS	-	-	-1.00	-	-
Diluted EPS	-	-	-1.00	-	-
Basic Shares Outstanding	69.93	69.38	63.53	67.62	40.27
Diluted Shares Outstanding	69.93	69.38	63.53	67.62	40.27